| scholarly article | Q13442814 |
| P2093 | author name string | Barry P Rosen | |
| Masafumi Yoshinaga | |||
| Luis D Garbinski | |||
| P2860 | cites work | The nature of Staphylococcus aureus MurA and MurZ and approaches for detection of peptidoglycan biosynthesis inhibitors | Q46082809 |
| Biochemical Characterization of ArsI: A Novel C-As Lyase for Degradation of Environmental Organoarsenicals. | Q47763169 | ||
| Alteration of a single amino acid residue reverses fosfomycin resistance of recombinant MurA from Mycobacterium tuberculosis | Q47904411 | ||
| Inhibition of Staphylococcus aureus Cell Wall Biosynthesis by Desleucyl-Oritavancin: a Quantitative Peptidoglycan Composition Analysis by Mass Spectrometry | Q50192704 | ||
| 2-Aminotetralones: novel inhibitors of MurA and MurZ. | Q52852098 | ||
| Sesquiterpene lactones are potent and irreversible inhibitors of the antibacterial target enzyme MurA. | Q54456599 | ||
| Characterization of a Cys115 to Asp substitution in the Escherichia coli cell wall biosynthetic enzyme UDP-GlcNAc enolpyruvyl transferase (MurA) that confers resistance to inactivation by the antibiotic fosfomycin. | Q54590227 | ||
| Thiolation in arsenic metabolism: a chemical perspective | Q57453957 | ||
| Arsinothricin, an arsenic-containing non-proteinogenic amino acid analog of glutamate, is a broad-spectrum antibiotic | Q64112958 | ||
| The antibiotic action of methylarsenite is an emergent property of microbial communities | Q90297801 | ||
| A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
| Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance | Q26853135 | ||
| A new view of the mechanisms of UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) and 5-enolpyruvylshikimate-3-phosphate synthase (AroA) derived from X-ray structures of their tetrahedral reaction intermediate states | Q27642065 | ||
| Identification of a novel UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) from Vibrio fischeri that confers high fosfomycin resistance in Escherichia coli | Q33416937 | ||
| A C⋅As lyase for degradation of environmental organoarsenical herbicides and animal husbandry growth promoters. | Q33694625 | ||
| Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes | Q33891890 | ||
| Arsenicals inhibit thioredoxin reductase in cultured rat hepatocytes | Q33938954 | ||
| The mechanism of action of fosfomycin (phosphonomycin) | Q34214482 | ||
| The composition of Ehrlich's salvarsan: resolution of a century-old debate | Q34380428 | ||
| Arsenic detoxification and evolution of trimethylarsine gas by a microbial arsenite S-adenosylmethionine methyltransferase | Q34478909 | ||
| Penicillin-binding protein 4 overproduction increases beta-lactam resistance in Staphylococcus aureus. | Q35126842 | ||
| Opposing effects of target overexpression reveal drug mechanisms | Q35535319 | ||
| Genomewide overexpression screen for fosfomycin resistance in Escherichia coli: MurA confers clinical resistance at low fitness cost | Q35941216 | ||
| ArsP: a methylarsenite efflux permease | Q36377611 | ||
| Earth Abides Arsenic Biotransformations | Q36462027 | ||
| Determination of multiple human arsenic metabolites employing high performance liquid chromatography inductively coupled plasma mass spectrometry | Q36566386 | ||
| A continuous spectrophotometric assay for inorganic phosphate and for measuring phosphate release kinetics in biological systems | Q37033872 | ||
| Cytoplasmic steps of peptidoglycan biosynthesis | Q37081699 | ||
| Arsenic-based antineoplastic drugs and their mechanisms of action | Q37145891 | ||
| Demethylation of methylarsonic acid by a microbial community | Q37147613 | ||
| Inhibition by methylated organo-arsenicals of the respiratory 2-oxo-acid dehydrogenases | Q37200043 | ||
| Mineral arsenicals in traditional medicines: orpiment, realgar, and arsenolite | Q37221305 | ||
| Fosfomycin: an old--new antibiotic | Q37931369 | ||
| Linking Genes to Microbial Biogeochemical Cycling: Lessons from Arsenic | Q38672376 | ||
| Synthesis and structure-activity relationship study of novel quinazolinone-based inhibitors of MurA. | Q38745942 | ||
| The organoarsenical biocycle and the primordial antibiotic methylarsenite | Q38978392 | ||
| Comparative toxicity of arsenic metabolites in human bladder cancer EJ-1 cells. | Q39495284 | ||
| Recurrent horizontal transfer of arsenite methyltransferase genes facilitated adaptation of life to arsenic. | Q40494874 | ||
| The Quorum Sensing Inhibitor Hamamelitannin Increases Antibiotic Susceptibility of Staphylococcus aureus Biofilms by Affecting Peptidoglycan Biosynthesis and eDNA Release | Q40811390 | ||
| ArsH is an organoarsenical oxidase that confers resistance to trivalent forms of the herbicide monosodium methylarsenate and the poultry growth promoter roxarsone. | Q41268773 | ||
| Organoarsenical Biotransformations by Shewanella putrefaciens | Q41836751 | ||
| Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli | Q43195414 | ||
| P304 | page(s) | 126911 | |
| P577 | publication date | 2020-04-27 | |
| P1433 | published in | Chemosphere | Q749724 |
| P1476 | title | Organoarsenicals inhibit bacterial peptidoglycan biosynthesis by targeting the essential enzyme MurA | |
| P478 | volume | 254 |
Search more.